{"id":485,"date":"2014-08-04T14:52:30","date_gmt":"2014-08-04T12:52:30","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/"},"modified":"2026-10-06T06:29:31","modified_gmt":"2026-10-06T03:29:31","slug":"zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/","title":{"rendered":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.<\/p>\n<p>\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas z\u0101\u013cu re\u0123istr\u0101 iek\u013caut\u0101s z\u0101les (tai skait\u0101 293 kompens\u0113jamo z\u0101\u013cu saraksta z\u0101les) par 18,94 miljoniem eiro, kas ir par 3% vair\u0101k nek\u0101 2014. gada 1. ceturksn\u012b.<\/p>\n<p>2014. gada otraj\u0101 ceturksn\u012b Latvij\u0101 darboj\u0101s 69 licenc\u0113tas z\u0101\u013cu lieltirgotavas. Pirmaj\u0101 viet\u0101 p\u0113c z\u0101\u013cu apgroz\u012bjuma eiro \u0161aj\u0101 laika period\u0101 bija lieltirgotava &#8220;Recipe Plus&#8221; ar 31 450 295 eiro lielu apgroz\u012bjumu (ar PVN), otraj\u0101 viet\u0101 aiz sevis atst\u0101jot &#8220;Tamro&#8221; ar 17 424 971 eiro apgroz\u012bjumu (ar PVN). Tre\u0161\u0101 liel\u0101k\u0101 z\u0101\u013cu lieltirgotava Latvij\u0101 gada otraj\u0101 ceturksn\u012b bijusi &#8220;Magnum Medical&#8221; ar 12 081 337 eiro apgroz\u012bjumu (ar PVN).<\/p>\n<p><strong>Z\u0101\u013cu realiz\u0101cija Latvij\u0101<\/strong><\/p>\n<p>2014. gada 2. ceturksnis\n<\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Lieltirgotavas nosaukums<\/strong><\/td>\n<td><strong>Apgroz\u012bjums eiro ar PVN<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td>Recipe Plus<\/td>\n<td>31 450 295<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Tamro<\/td>\n<td>17 424 971<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Magnum Medical<\/td>\n<td>12 081 337<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>GlaxoSmithKline Latvia<\/td>\n<td>5 921 011<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Euroaptieka<\/td>\n<td>5 348 120<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Roche Latvija<\/td>\n<td>4 344 932<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Oriola R\u012bga<\/td>\n<td>3 821 956<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Vakc\u012bna<\/td>\n<td>2 797 861<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Medelens<\/td>\n<td>2 312 807<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Elpis<\/td>\n<td>2 211 025<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td>Saules aptieka<\/td>\n<td>2 090 603<\/td>\n<\/tr>\n<tr>\n<td>12<\/td>\n<td>Merck Serono<\/td>\n<td>2 064 149<\/td>\n<\/tr>\n<tr>\n<td>13<\/td>\n<td>Briz<\/td>\n<td>1 998 739<\/td>\n<\/tr>\n<tr>\n<td>14<\/td>\n<td>Meda Pharma<\/td>\n<td>1 879 407<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td>Olainfarm<\/td>\n<td>1 565 565<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\"><strong>Kop\u0101<em> (visas licenc\u0113t\u0101s z\u0101\u013cu lieltirgotavas)<\/em><\/strong><\/td>\n<td><strong>106 777 385<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>\u00a0<\/strong><strong>Z\u0101\u013cu realiz\u0101cija visp\u0101r\u0113ja tipa aptiek\u0101m, prakses \u0101rstiem un \u0101rstniec\u012bbas iest\u0101d\u0113m<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Lieltirgotavas nosaukums<\/strong><\/td>\n<td><strong>Apgroz\u012bjums eiro ar PVN<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td>Recipe Plus<\/td>\n<td>26 777 399<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Tamro<\/td>\n<td>15 694 186<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Magnum Medical<\/td>\n<td>10 668 439<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Euroaptieka<\/td>\n<td>5 348 120<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Oriola R\u012bga<\/td>\n<td>3 428 536<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Vakc\u012bna<\/td>\n<td>2 741 235<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Medelens<\/td>\n<td>2 305 741<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Olainfarm<\/td>\n<td>1 563 421<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Baltfarm lieltirgotava &#8220;Vita-farm&#8221;<\/td>\n<td>1 537 348<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Jelgavfarm<\/td>\n<td>1 086 149<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td>Saules aptieka<\/td>\n<td>871 452<\/td>\n<\/tr>\n<tr>\n<td>12<\/td>\n<td>Elpis<\/td>\n<td>731 681<\/td>\n<\/tr>\n<tr>\n<td>13<\/td>\n<td>B.Braun Medical<\/td>\n<td>699 975<\/td>\n<\/tr>\n<tr>\n<td>14<\/td>\n<td>GlaxoSmithKline Latvia<\/td>\n<td>620 195<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td>Unifarma<\/td>\n<td>456 578<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\"><strong>Kop\u0101<em> (visas licenc\u0113t\u0101s z\u0101\u013cu lieltirgotavas)<\/em><\/strong><\/td>\n<td><strong>76 972 219<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>\u00a0<\/strong><strong>Z\u0101\u013cu realiz\u0101cija visp\u0101r\u0113ja tipa aptiek\u0101m<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Lieltirgotavas nosaukums<\/strong><\/td>\n<td><strong>Apgroz\u012bjums eiro ar PVN<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td>Recipe Plus<\/td>\n<td>24 764 689<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Tamro<\/td>\n<td>13 234 302<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Magnum Medical<\/td>\n<td>9 932 163<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Euroaptieka<\/td>\n<td>5 348 120<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Oriola R\u012bga<\/td>\n<td>2 589 401<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Medelens<\/td>\n<td>2 080 638<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Olainfarm<\/td>\n<td>1 563 421<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Baltfarm lieltirgotava &#8220;Vita-farm&#8221;<\/td>\n<td>1 537 348<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Jelgavfarm<\/td>\n<td>1 032 946<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Saules aptieka<\/td>\n<td>856 886<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td>Elpis<\/td>\n<td>398 177<\/td>\n<\/tr>\n<tr>\n<td>12<\/td>\n<td>Baltacon<\/td>\n<td>394 964<\/td>\n<\/tr>\n<tr>\n<td>13<\/td>\n<td>GlaxoSmithKline Latvia<\/td>\n<td>268 578<\/td>\n<\/tr>\n<tr>\n<td>14<\/td>\n<td>Roche Latvija<\/td>\n<td>204 043<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td>Elvim<\/td>\n<td>141 645<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\"><strong>Kop\u0101<em> (visas licenc\u0113t\u0101s z\u0101\u013cu lieltirgotavas)<\/em><\/strong><\/td>\n<td><strong>64 956 086<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\n\u00a0<\/p>\n<p>Datu avots: Z\u0101\u013cu lieltirgotavu iesniegtie p\u0101rskati Z\u0101\u013cu valsts a\u0123ent\u016brai. Vair\u0101k inform\u0101cijas par z\u0101\u013cu apgroz\u012bjumu 2014. gada 2. ceturksn\u012b atrad\u012bsit \u0161eit: <a href=\"http:\/\/www.zva.gov.lv\/?id=679&amp;sa=323&amp;top=3\">http:\/\/www.zva.gov.lv\/\/?id=679&amp;sa=323&amp;top=3<\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><a href=\"http:\/\/www.farmacija-mic.lv\">www.farmacija-mic.lv<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76,7,74],"tags":[],"mic_flag":[62],"class_list":["post-485","post","type-post","status-publish","format-standard","hentry","category-farmacijas-zinas","category-jaunakie-raksti","category-statistika","category-svarigi","mic_flag-svarigi"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-08-04T12:52:30+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:29:31+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"position\":2,\"name\":\"Statistika\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#listItem\",\"name\":\"Z\\u0101\\u013cu apgroz\\u012bjums 2014. gada 2. ceturksn\\u012b \\u2013 par 1% liel\\u0101ks k\\u0101 attiec\\u012bg\\u0101 period\\u0101 p\\u0113rn\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#listItem\",\"position\":3,\"name\":\"Z\\u0101\\u013cu apgroz\\u012bjums 2014. gada 2. ceturksn\\u012b \\u2013 par 1% liel\\u0101ks k\\u0101 attiec\\u012bg\\u0101 period\\u0101 p\\u0113rn\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#newsarticle\",\"name\":\"Z\\u0101\\u013cu apgroz\\u012bjums 2014. gada 2. ceturksn\\u012b \\u2013 par 1% liel\\u0101ks k\\u0101 attiec\\u012bg\\u0101 period\\u0101 p\\u0113rn - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Z\\u0101\\u013cu apgroz\\u012bjums 2014. gada 2. ceturksn\\u012b \\u2013 par 1% liel\\u0101ks k\\u0101 attiec\\u012bg\\u0101 period\\u0101 p\\u0113rn\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"datePublished\":\"2014-08-04T14:52:30+03:00\",\"dateModified\":\"2026-10-06T06:29:31+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Statistika, Svar\\u012bgi, Svar\\u012bgi\",\"dateline\":\"Published on August 4, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/\",\"name\":\"Z\\u0101\\u013cu apgroz\\u012bjums 2014. gada 2. ceturksn\\u012b \\u2013 par 1% liel\\u0101ks k\\u0101 attiec\\u012bg\\u0101 period\\u0101 p\\u0113rn - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"2014. gada otraj\\u0101 ceturksn\\u012b z\\u0101\\u013cu lieltirgotavu kop\\u0113jais z\\u0101\\u013cu realiz\\u0101cijas apgroz\\u012bjums Latvij\\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\\u0101k, sal\\u012bdzinot ar 2014. gada 1. ceturksni, zi\\u0146o Z\\u0101\\u013cu valsts a\\u0123ent\\u016bra (ZVA). Sal\\u012bdzin\\u0101jum\\u0101 ar 2013. gada otro ceturksni kop\\u0113jais z\\u0101\\u013cu apgroz\\u012bjums ir palielin\\u0101jies par 1 %.\\u0100rpus Latvijas 2014. gada otraj\\u0101 ceturksn\\u012b realiz\\u0113tas 676 da\\u017e\\u0101du nosaukumu Latvijas\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"datePublished\":\"2014-08-04T14:52:30+03:00\",\"dateModified\":\"2026-10-06T06:29:31+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs","description":"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas","canonical_url":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","position":2,"name":"Statistika","item":"https:\/\/farmacija-mic.lv\/category\/statistika\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#listItem","name":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#listItem","position":3,"name":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#newsarticle","name":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs","headline":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"datePublished":"2014-08-04T14:52:30+03:00","dateModified":"2026-10-06T06:29:31+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Statistika, Svar\u012bgi, Svar\u012bgi","dateline":"Published on August 4, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/","name":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs","description":"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"datePublished":"2014-08-04T14:52:30+03:00","dateModified":"2026-10-06T06:29:31+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs","og:description":"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas","og:url":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/","article:published_time":"2014-08-04T12:52:30+00:00","article:modified_time":"2026-10-06T03:29:31+00:00","twitter:card":"summary_large_image","twitter:title":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn - Medikamentu Inform\u0101cijas Centrs","twitter:description":"2014. gada otraj\u0101 ceturksn\u012b z\u0101\u013cu lieltirgotavu kop\u0113jais z\u0101\u013cu realiz\u0101cijas apgroz\u012bjums Latvij\u0101 bija 106,78 miljoni eiro, kas ir par 4% maz\u0101k, sal\u012bdzinot ar 2014. gada 1. ceturksni, zi\u0146o Z\u0101\u013cu valsts a\u0123ent\u016bra (ZVA). Sal\u012bdzin\u0101jum\u0101 ar 2013. gada otro ceturksni kop\u0113jais z\u0101\u013cu apgroz\u012bjums ir palielin\u0101jies par 1 %.\u0100rpus Latvijas 2014. gada otraj\u0101 ceturksn\u012b realiz\u0113tas 676 da\u017e\u0101du nosaukumu Latvijas"},"aioseo_meta_data":{"post_id":"485","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-23 01:33:57","updated":"2026-10-07 12:35:14"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/statistika\/\" title=\"Statistika\">Statistika<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tZ\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Statistika","link":"https:\/\/farmacija-mic.lv\/category\/statistika\/"},{"label":"Z\u0101\u013cu apgroz\u012bjums 2014. gada 2. ceturksn\u012b \u2013 par 1% liel\u0101ks k\u0101 attiec\u012bg\u0101 period\u0101 p\u0113rn","link":"https:\/\/farmacija-mic.lv\/en\/zalu-apgrozijums-2014-gada-2-ceturksni-par-1-lielaks-ka-attieciga-perioda-pern\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=485"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/485\/revisions"}],"predecessor-version":[{"id":2215,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/485\/revisions\/2215"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=485"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}